. Author manuscript; available in PMC: 2021 Jan 1.

Published in final edited form as: J Hepatol. 2019 Oct 18;72(1):25–33. doi: 10.1016/j.jhep.2019.10.006

Table 3.

Statin use by treatment group

Statin use history	OCA (n=98)^*	Placebo (n=97)	P-value
			0.60
Not taking at baseline, week 12 or 72	33 (34%)	39 (40%)
Taking at baseline, week 12 and F72	46 (47%)	39 (40%)
Transient use at baseline, week 12 and 72	19 (19%)	19 (20%)

Excludes one patient with missing statin use data at F12 and F72